Main Content
  • University of Maryland Medicine Tests Novel Treatment for Parkinson's

    University of Maryland Medicine (the University of Maryland Medical Center and the University of Maryland School of Medicine) and its Center for Metabolic Imaging and Image-Guided Therapeutics (CMIT) has begun to use MRI-guided focused ultrasound on a deep structure within the brain related to Parkinson’s disease – the globus pallidus.


  • Study by University of Maryland School of Medicine Researcher Finds a Major Lack of Community Resources for Patients in Malawi Following Rehabilitation

    Malawi has a population of 16 million, yet, only one inpatient rehabilitation center for individuals with stroke, spinal cord injury, and similar conditions. With just 40 beds, the Kachere Rehabilitation Center in Blantyre, Malawi’s second largest city, provides services to the entire country. Because there is little funding for rehabilitation in the country, there is essentially no rehabilitation and follow-up services for patients after they return to their families, homes, and communities.


  • Use of Contact Precautions to Prevent Spread of MRSA and VRE in Hospitalized Patients Should Be Customized Based on Local Needs and Resources

    Contact precautions are recommended by the Centers for Disease Control and Prevention (CDC) for all patients known to be infected with or carrying multidrug-resistant organisms (MDROs) such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). Yet, the use of contact precautions—which require a patient to be isolated in a single hospital room and health care providers to wear a gown and gloves when caring for patients—is widely debated in the medical community.


  • Patent Expirations for Blockbuster Antipsychotic Medications May Save Billions, According to New Research From the University of Maryland School of Medicine

    Medicaid is expected to save billions of dollars a year as patents for several blockbuster antipsychotic medications expire and use of generic versions of these drugs increases, according to a new study by researchers at the University of Maryland School of Medicine. These savings may provide relief from the high costs of these medications and allow policymakers to lift restrictions on patients’ access, the researchers argue.


  • University of Maryland School of Medicine To Establish New Mesothelioma and Thoracic Oncology Treatment and Research Center

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, today announced the establishment of the University of Maryland School of Medicine Mesothelioma and Thoracic Oncology Treatment and Research Center. The multi-disciplinary Center will enable the School to conduct research, treatment, and education in thoracic oncology to help those suffering from mesothelioma, a rare but often fatal form of cancer that affects the lungs, chest, heart and abdomen, most commonly caused by exposure to asbestos.



News Archive » Submit News » RSS
Publication Archives »

State of the School School of Medicine Rankings Meet Our Students Make a Difference - Make a Gift